tiprankstipranks
Vyne Therapeutics Inc (VYNE)
:VYNE
US Market

VYNE Therapeutics (VYNE) Technical Analysis

Compare
1,829 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Vyne Therapeutics Inc’s (VYNE) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting Vyne Therapeutics Inc is a Buy.
Vyne Therapeutics Inc’s (VYNE) 20-Day exponential moving average is 1.97, while Vyne Therapeutics Inc’s (VYNE) share price is $1.71, making it a Sell.
Vyne Therapeutics Inc’s (VYNE) 50-Day exponential moving average is 2.27, while Vyne Therapeutics Inc’s (VYNE) share price is $1.71, making it a Sell.

VYNE Therapeutics (VYNE) Pivot Points

Mar 27, 2025, 07:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.36
1.52
1.63
1.79
1.90
2.06
2.17
Fibonacci
1.52
1.62
1.69
1.79
1.89
1.96
2.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VYNE Therapeutics (VYNE) Moving Averages

Mar 27, 2025, 07:01 PM
Period
Simple
Exponential
MA5
1.72Sell
1.74Sell
MA10
1.77Sell
1.80Sell
MA20
2.00Sell
1.97Sell
MA50
2.34Sell
2.27Sell
MA100
2.64Sell
2.41Sell
MA200
2.31Sell
2.35Sell
Vyne Therapeutics Inc’s (VYNE) 10-Day exponential moving average is 1.80, while Vyne Therapeutics Inc’s (VYNE) share price is $1.71, making it a Sell.
Vyne Therapeutics Inc’s (VYNE) 100-Day exponential moving average is 2.41, while Vyne Therapeutics Inc’s (VYNE) share price is $1.71, making it a Sell.
Vyne Therapeutics Inc’s (VYNE) stock price is $1.71 and Vyne Therapeutics Inc’s (VYNE) 50-day simple moving average is 2.34, creating a Sell signal.
Vyne Therapeutics Inc’s (VYNE) stock price is $1.71 and Vyne Therapeutics Inc’s (VYNE) 100-day simple moving average is 2.64, creating a Sell signal.
Vyne Therapeutics Inc’s (VYNE) stock price is $1.71 and Vyne Therapeutics Inc’s (VYNE) 200-day simple moving average is 2.31, creating a Sell signal.

VYNE Therapeutics (VYNE) Technical Indicators

Mar 27, 2025, 07:01 PM
Name
Value
Implied Action
RSI (14)
28.57
Buy
STOCH (9,6)
29.26
Neutral
STOCHRSI (14)
12.79
Buy
MACD (12,26)
-0.21
Buy
ADX (14)
31.77
Neutral
Williams %R
-88.87
Buy
CCI (14)
-78.02
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
29.77
Sell
ROC
-26.61
Sell
Vyne Therapeutics Inc’s (VYNE) Relative Strength Index (RSI) is 28.57, creating a Buy signal.
Vyne Therapeutics Inc’s (VYNE) Trend Strength Indicator (ADX) is 31.77, creating a Neutral signal.
Vyne Therapeutics Inc’s (VYNE) Commodity Channel Index (CCI) is -78.02, creating a Neutral signal.
Vyne Therapeutics Inc’s (VYNE) Price Rate of Change (ROC) is -26.61, creating a Sell signal.

FAQ

Is VYNE a Buy, Hold, or Sell?
Based on VYNE’s technical indicators, VYNE is a Strong Sell.
    What is VYNE’s RSI (14)?
    VYNE’s RSI (14) is 28.57, which suggests VYNE is a Buy.
      What is VYNE’s MACD?
      VYNE’s MACD is -0.21, which suggests VYNE is a Buy.
        What is VYNE’s 5-day moving average?
        VYNE’s 5-day moving average is 1.72, which suggests VYNE is a Sell.
          What is VYNE’s 20-day moving average?
          VYNE 20-day moving average is 2.00, which suggests VYNE is a Sell.
            What is VYNE’s 50-day moving average?
            VYNE’s 50-day moving average is 2.34, which suggests VYNE is a Sell.
              What is VYNE’s 200-day moving average?
              VYNE’s 200-day moving average is 2.31, which suggests VYNE is a Sell.
                What is VYNE’s Williams % R (14)?
                VYNE’s Williams % R (14) is -88.87, which suggests VYNE is a Buy.
                  What is VYNE’s CCI (14)?
                  VYNE’s CCI (14) is -78.02, which suggests VYNE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis